Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profileg
Ryan Huey, MD, MS

@ryanhuey

GI Medical Oncologist, @MDAndersonNews: unknown primary, colon, and pancreatic cancer + value-based cancer care delivery. @UTexasValue MSHCT alum. Tweets mine.

ID:15971685

linkhttps://faculty.mdanderson.org/profiles/ryan_huey.html calendar_today24-08-2008 19:13:20

4,5K Tweets

1,8K Followers

864 Following

MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

Savannah Kaspar faced many unknowns when she was diagnosed with colon cancer at age 26.

Learn how support from family, friends and coworkers at MD Anderson helped her through treatment: brnw.ch/21wIdn3 Ryan Huey, MD, MS

account_circle
Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profile Photo

Had FOMO by not seeing my friend Michael Frumovitz talk at , but saw him today thanks to Ovarcome. Tremendous perspective on the MD as the pt: who is affected by illness, the power of hope, and the importance of living in community. Value Institute for Health and Care at UT Austin MD Anderson Cancer Center Beth Comcowich Garcia

Had FOMO by not seeing my friend @Frumovitz talk at #SGOMtg, but saw him today thanks to @ovarcome. Tremendous perspective on the MD as the pt: who is affected by illness, the power of hope, and the importance of living in community. @UTexasValue @MDAndersonNews @BethGarciaMDA
account_circle
Peter WT Pisters, MD(@ppisters) 's Twitter Profile Photo

Pleased to join our MD Anderson Cancer Center - Aichi Cancer Center Joint Cancer Symposium. It was great to connect with these remarkable colleagues and speak to MD Anderson’s focus on the future as we advance new breakthroughs.

Pleased to join our @MDAndersonNews - Aichi Cancer Center Joint Cancer Symposium. It was great to connect with these remarkable colleagues and speak to MD Anderson’s focus on the future as we advance new breakthroughs. #EndCancer
account_circle
Clay Davis(@Coach_C_Davis) 's Twitter Profile Photo

Got your blue on today? March 1st marks the beginning of colorectal awareness month. Wear blue today in honor of all those who are fighting and who have fought💙💙💙 MD Anderson Cancer Center Ryan Huey, MD, MS AliveAndKickn

Got your blue on today? March 1st marks the beginning of colorectal awareness month. Wear blue today in honor of all those who are fighting and who have fought💙💙💙 @MDAndersonNews @ryanhuey @Alive_And_Kickn
account_circle
Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profile Photo

.Van Morris, MD w/ COBRA in Stage II colon cancer, ctDNA as a predictive biomarker. Surveillance arm had 43% ctDNA clearance vs 11% in chemo arm.

.@VanMorrisMD w/ COBRA in Stage II colon cancer, ctDNA as a predictive biomarker. Surveillance arm had 43% ctDNA clearance vs 11% in chemo arm. #GI24
account_circle
Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profile Photo

.Gabriel Brooks with a summary of chemotherapy toxicity management for CRC. Highlights DPD deficiency screening and oxaliplatin duration. Europe far ahead of the US for DPD def screening. IDEA helped with oxali duration.

.@gabe_a_brooks with a summary of chemotherapy toxicity management for CRC. Highlights DPD deficiency screening and oxaliplatin duration. Europe far ahead of the US for DPD def screening. IDEA helped with oxali duration. #GI24
account_circle
Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profile Photo

Fiber, barrier creams, loperamide, all important supportive care approaches for LARs. Some data for ondansetron; physical activity is important! Walking 20-30 mins 3x/wk can improve QOL and bowel fxn.

Fiber, barrier creams, loperamide, all important supportive care approaches for LARs. Some data for ondansetron; physical activity is important! Walking 20-30 mins 3x/wk can improve QOL and bowel fxn. #GI24
account_circle
Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profile Photo

Dr. Temple brings up the interesting question of the role of local excision for pts w/ rectal cancer who have an incomplete response to total neoadjuvant therapy, could limit LARS? Future trials to assess.

Dr. Temple brings up the interesting question of the role of local excision for pts w/ rectal cancer who have an incomplete response to total neoadjuvant therapy, could limit LARS? Future trials to assess. #GI24
account_circle
Ryan Huey, MD, MS(@ryanhuey) 's Twitter Profile Photo

Dr. Larissa Temple discussed low anterior resection syndrome, present in about 70% of patients who have LAR surgery, 40% persist throughout life.

Dr. Larissa Temple discussed low anterior resection syndrome, present in about 70% of patients who have LAR surgery, 40% persist throughout life. #GI24
account_circle